Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID biodynamic haematogel plus usual care for diabetic foot ulcers
ISRCTN55474813Phase 2Suspended
- Sponsor
- Biotherapy Services Limited
- Start
- Mar 2019
- Modality
- Cell Therapies
01
Overview
Phase 2, randomised, open-label trial of Angel PRP gel in diabetic foot ulcer (DFU) (2 arms), sponsored by Biotherapy Services Limited. Primary endpoint: The proportion of healed diabetic foot ulcers at 12 weeks. Started Mar 2019; status: suspended.
02
Drugs
Angel PRP gel
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ISRCTN55474813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN55474813.